Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

16 May 2015 Reuters Investment Profile 12 $20.00

Cipla Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 May 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - CIPLA LTD (CIPLA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

22 May 2015 Thomson Reuters Stock Report 11 $25.00

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review

Cipla Ltd. (CIPLA) - Financial and Strategic SWOT Analysis Review Summary Cipla Ltd. (Cipla) is a global pharmaceutical compa...

19 May 2015 GlobalData 48 $125.00

Wright Investors Service Comprehensive Report for Cipla Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

18 May 2015 Wright Reports 56 $75.00

Cipla Ltd.- Q3FY15 Result Update - "ACCUMULATE" - KRChoksey Research - “Long term story intact”

“Long term story intact” Result highlights Cipla’s Q3FY15 results were below street & our estimates. Total income grew by 6.5...

16 Feb 2015 Kisan Ratilal Choksey Shares and Securities Private Limited 7 $58.00

MOSL: CIPLA (Buy) - Operationally in line - await revenue scale-up

CIPLA 3QFY15: Operationally in line; await revenue scale-up (CIPLA IN, Mkt Cap USD8.5b, CMP INR662, TP INR755, 14% Upside, ...

13 Feb 2015 Motilal Oswal Securities Ltd. 12 $115.00

Cipla Ltd. (CIPLA) - Qtr. Update - Dated - February 12, 2015

Cipla (Bloomberg: CIPLA IN, BUY, TP – Rs 740; 12% upside from CMP of Rs 662) Cipla’s Q3 PAT (Rs 3.3 bn, +15% YoY) was 13% ...

13 Feb 2015 Axis Capital Limited 6 $58.00

Cipla Ltd.| Q3FY15 Result Update | Weak operational performance off-set to some extent by higher other operating income | Maintain HOLD rating with revise our price target to Rs653 (from Rs644 earlier)

Cipla Ltd.| Q3FY15 Result Update Weak operational performance off-set to some extent by higher other operating income | Mai...

13 Feb 2015 IndiaNivesh Securities Pvt Ltd 6 $58.00

CIPL.NS - Event Transcript of Cipla Ltd conference call, Feb. 12, 2015 / 9:00AM ET

Edited Event Transcript of CIPL.NS conference call, Feb. 12, 2015 / 9:00AM ET Boston, Feb 12, 2015 (Thomson StreetEvent...

12 Feb 2015 Thomson Reuters StreetEvents 19 $75.00